Central Nervous System Hemangioblastoma
generalA rare, highly vascular, WHO grade I tumor that arises from the central nervous system and is composed of abundant capillaries and stromal cells. It can occur sporadically or as part of von Hippel-Lindau syndrome. It is a slow growing tumor with a low risk of metastasis, despite its benign histological features.
3
Centers
0
Active Trials
$1.4B
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Retinal Hemangioblastoma | 3 |
Top Centers for Central Nervous System Hemangioblastoma(3)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | — |
| 2 | Duke Cancer InstituteDurham, NC NCI Comprehensive | — |
| 3 | Boston University Cancer CenterBoston, MA | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →